Leptin Serum Levels are Associated With GLP-1 Receptor Agonist-Mediated Effects on Glucose Metabolism in Clozapine- or Olanzapine-Treated, Prediabetic, Schizophrenia Patients.
Overview & Synopsis
Open access biomedical research article published in Schizophr Bull Open.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Leptin Serum Levels are Associated With GLP-1 Receptor Agonist-Mediated Effects on Glucose Metabolism in Clozapine- or Olanzapine-Treated, Prediabetic, Schizophrenia Patients. |
|---|---|
| Author / Organization | Tomasik J, Rustogi N, Larsen JR, Jakobsen MI, Svensson CK, Vedtofte L, Jakobsen MSL, Jespersen HR, Koyuncu K, Schjerning O, Nielsen J, Ekstrøm CT, Correll CU, Holst JJ, Vilsbøll T, Bahn S, Fink-Jensen A |
| Subject & Discipline | Schizophr Bull Open |
| Categories | Medicine & Health |
| Publication Year | 2020 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-114763 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |